It is currently Fri Jul 29, 2016 9:11 am
- Consistent with previously announced results from the initial Phase 3 trial, remaining trials fail to show superiority over placebo -
- Pre-specified subgroup analyses of pooled U.S. patients demonstrated a statistically significant result for the primary endpoint and a number of secondary endpoints -
- GW and Otsuka have submitted a request to meet with FDA to discuss clinical relevance of U.S. data and ...
Total posts 233468 • Total topics 25051 • Total members 16209